      <div class="section fp-auto-height">
          <div class="main-content">
          <div class="page-head"><h2>ERS Assembly 11: Thoracic Oncology</h2></div>

            <div class="row">
             
                <div class="col-md-3 col-md-offset-3 xs-mb-15">
                  <img src="https://cdn.ersnet.org/images/people/leadership/Jan-Van-Meerbeeck.png" class="img-circle">
                  <p class="photo_caption">Head: Jan Van Meerbeeck</p>
                </div>

                <div class="col-md-3 xs-mb-15">
                  <img src="https://cdn.ersnet.org/images/people/leadership/Thorsten-BLUM.png" class="img-circle">
                  <p class="photo_caption">Secretary: Torsten Gerriet Blum</p>
                 
                </div>
            </div>
            <div class="col-md-6 center-block">
              <p >Assembly Early Career representative: Adrien Costantini</p>
            </div>
            <div class="col-md-6 center-block lead">
              Respiratory tumours are a major part of daily practice for many respiratory physicians. Assembly 11 focuses on all aspects of lung cancer, mesothelioma, mediastinal tumours and lung metastases. The work of members includes epidemiology and prevention; biology and pathology; diagnosis and staging; multidisciplinary approaches in therapy; systemic treatment with chemotherapy and targeted agents; and follow-up and supportive care. There is a close cooperation with theImaging, Interventional Respiratory Medicine, Radiotherapy, Biology and Thoracic Surgery Groups, now formalised into the Thoracic Oncology Network of the ERS. 
The Assembly aims to reinforce the role of respiratory physicians in this area practice by establishing practice guidelines, cooperating with other societies and organising dedicated school courses and symposia on contemporary clinical questions. 
The Assembly has developed an action plan for Thoracic Oncology in Europe, fully supported by the ERS Executive Committee. The ongoing actions include the creation of a Task Force for quality management of lung cancer or the development of a multidisciplinary HERMES programme for training in thoracic oncology. <br>
The Assembly is comprised of the following two groups:


            </div>


          

            <div class="rowã€€row_assemblies_card clearfix">
              <div class="col-md-4 col-md-offset-2">
                 <div class="card card-padded">
                  <div class="card-image">
                  </div>
                  <div class="card-title text-left">
                    <h3>Lung Cancer</h3>
                  </div> 
                  <div class="card-content text-left">
                    <p>Group 11.01<br>
                    Chair: Rudolf M. Huber<br>
                    Secretary: Georgia Hardavella</p>
                  </div>
                  <div class="card-action clearfix">
                    <button data-toggle="modal" data-target="#md-lung-cancer" type="button" class="btn btn-default pull-right">More</button>
                  </div>
                </div>
              </div>
                
               <div class="col-md-4">
                <div class="card card-padded">
                  <div class="card-image">
                  </div>
                  <div class="card-title text-left">
                    <h3>Pleural and Mediastinal Malignancies</h3>
                  </div> 
                  <div class="card-content text-left">
                    <p>Group 11.02<br>
                    Chair: Najib M. Rahman<br>
                    Secretary: Kevin Blyth</p>
                  </div>
                  <div class="card-action clearfix">
                    <button data-toggle="modal" data-target="#md-pleural-and-mediastinal" type="button" class="btn btn-default pull-right">More</button>
                  </div>
                </div>
              </div>
            </div>

          </div>  
        </div>


















